Dr. Steven Galetta Receives Lifetime Achievement Award
NYU Langone neurology chair Dr. Steven Galetta awarded lifetime achievement recognition.
Dr. Sunil Rao Named Director of Interventional Cardiology
NYU Langone names Dr. Sunil Rao director of interventional cardiology and director of its Cardiac Catheterization Laboratory in Manhattan.
Dr. Tamas A. Gonda Joins NYU Langone Health
Renowned advanced endoscopist and translational researcher Dr. Tamas A. Gonda is appointed director of NYU Langone’s Pancreatic Disease Program.
Dr. Wong Named Chief of Hematology & Medical Oncology
World-renowned clinician-scientist Kwok-Kin Wong, MD, PhD, joins NYU Langone as the new chief of hematology and medical oncology.
Drinking Affects Bacterial Mix in the Mouth
NYU Langone study shows that drinking one or more alcoholic drinks per day affects the mix of bacteria in the mouth.
Drug Blocks 75 Percent of Lung Cancers with Rare Mutation
Dr. Joshua K. Sabari, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, discusses a new non-small cell lung cancer drug.
Drug Combination Could Starve Pancreatic Cancer
NYU Langone experts leverage newfound combination of mechanisms to starve pancreatic tumors.
Drug Combo Overcomes Treatment Resistance in Blood Cancer
NYU Langone study shows that resistance of leukemia cells to venetoclax occurs because of a rapid increase in breakdown of mitochondria.
Drug Decriminalization Not Linked to More Overdose Deaths
NYU Langone study suggests there is no evidence of an association between drug decriminalization and fatal drug overdose rates.
Drug Effective for Metastatic Triple Negative Breast Cancer
NYU Langone study finds pembrolizumab is effective in shrinking tumors among metastatic triple negative breast cancer patients.